Replies to post #210752 on Biotech Values

[DewDiligence]

I have to consider AZN as a much less sexier but much safer potential China play.

I would suggest ABT for that role. ABT has a big business in China not only in pharmaceuticals (branded generics), but also in medical devices, diagnostics, and nutrition products.

[maumar]

"Keeping an eye on BGNE as a potential China play."

It's breaking out again on pretty high volume.